Table 1 describes the progress of various p53 gene therapies. Some researchers have proposed directly introducing p53 protein into tumor cells [22,23], but this approach faces challenges due to the short half-life of protein molecules and the complexities involved in their purification. Here, TP53 is linked to neoplasm.